Literature DB >> 6194392

Detection of RNA complementary to herpes simplex virus in human oral squamous cell carcinoma.

R P Eglin, C Scully, T Lehner, P Ward-Booth, I A McGregor.   

Abstract

Biopsy specimens from patients with oral squamous cell carcinoma were examined by in situ hybridisation for evidence of RNA complementary to herpes simplex virus (HSV) type 1, HSV type 2, and adenovirus type 2. RNA complementary to HSV was found in 66% of carcinomas and 33% of non-malignant lesions from other patients. In a further study with internally paired controls, RNA complementary to HSV was found in 53% of carcinoma biopsy specimens but in no biopsy specimens of normal oral mucosa from the same patients. RNA complementary to HSV was found in over 50% of oral squamous cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194392     DOI: 10.1016/s0140-6736(83)92299-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Assesment of Correlation of Herpes Simplex Virus-1 with Oral Cancer and Precancer- A Comparative Study.

Authors:  Mayuri Jain
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 2.  The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.

Authors:  C Simhandl; K Meszaros
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

3.  Detection of human papillomavirus DNA in biopsies of human oral tissue.

Authors:  N J Maitland; M F Cox; C Lynas; S S Prime; C A Meanwell; C Scully
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

Review 4.  Evidences suggesting involvement of viruses in oral squamous cell carcinoma.

Authors:  Kanupriya Gupta; Rashmi Metgud
Journal:  Patholog Res Int       Date:  2013-12-19

Review 5.  Emerging and changing viral diseases in the new millennium.

Authors:  C Scully; L P Samaranayake
Journal:  Oral Dis       Date:  2015-08-06       Impact factor: 3.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.